Revelation Biosciences Inc (REVBU)
$0.29
$0.00 (0.00%)As on 20-Jan-2023 09:30EDT
Market cap
$-- Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-4.6 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
0
-
Debt to Equity
--
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
0
Years Aggregate
CFO
$--
EBITDA
$--
Net Profit
$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Revelation Biosciences Inc (REVBU)
| 23.3 | 20.7 | -14.8 | -97.1 | -- | -- | -- |
|
BSE Sensex*
| -9.6 | -2.7 | 2.9 | -5.0 | 5.4 | 5.7 | 10.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Revelation Biosciences Inc (REVBU)
|
0.3 | -- | 0.0 | -9.0 | -- | -- | -- | 0.0 |
| 13.5 | 850.9 | 0.0 | -175.9 | -- | -106.8 | -- | 5.7 | |
| 14.1 | 2,151.8 | 549.1 | 17.9 | -6.3 | 1.4 | 123.8 | 1.7 | |
| 4.8 | 1,111.4 | 4.5 | -340.2 | -518.6 | 501.4 | -- | 2.1 | |
| 12.9 | 587.5 | 0.0 | -29.0 | 0.0 | -20.4 | -- | 2.0 | |
| 17.3 | 2,261.9 | 120.3 | -57.5 | -108.2 | -9.9 | -- | 4.1 | |
| 11.3 | 828.1 | 366.5 | 9.3 | 8.3 | 3.4 | 83.6 | 3.1 | |
| 3.7 | 654.8 | 4.1 | -187.9 | -4,613.1 | -233.9 | -- | 0.3 | |
| 14.7 | 834.1 | 0.6 | -60.0 | -9,892.6 | -119 | -- | 21.8 | |
| 26.1 | 2,927.9 | 449.6 | -188.2 | -41.1 | -28.5 | -- | 5.0 |
Shareholding Pattern
View DetailsAbout Revelation Biosciences Inc (REVBU)
Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company engages in developing therapeutic product candidates, including... REVTx-100, a potential therapy for the prevention and treatment of healthcare-associated bacterial infection resulting from surgery, severe burns, and antibiotic resistance; REVTx-200, a potential intranasal therapy; and REVTx-300, a potential therapy for the treatment of chronic organ disease, including chronic kidney disease and non-alcoholic steatohepatitis. It is also developing REVTx-99b, a treatment for food allergies; REVTx-99a, an anti-viral nasal drop solution for the potential prevention or treatment of respiratory viral infection; and REVDx-501, a rapid test kit, which is a point of care in vitro diagnostic test that has the potential to detect respiratory viral infections, such as SARS-CoV-2, influenza A, influenza B, parainfluenza, or respiratory syncytial virus. The company was founded in 2020 and is based in San Diego, California. Read more
-
CEO & Director
Mr. James M. Rolke
-
CEO & Director
Mr. James M. Rolke
-
Headquarters
San Diego, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Revelation Biosciences Inc (REVBU)
What is the current share price of Revelation Biosciences Inc (REVBU) Today?
The share price of Revelation Biosciences Inc (REVBU) is $0.29 (NASDAQ) as of 20-Jan-2023 09:30 EDT. Revelation Biosciences Inc (REVBU) has given a return of -97.11% in the last 1 years.
What is the current PB & PE ratio of Revelation Biosciences Inc (REVBU)?
Since, TTM earnings of Revelation Biosciences Inc (REVBU) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2021 |
-2.03 |
-0.55 |
2020 |
-- |
-- |
2021 |
-2.03 |
-0.55 |
2020 |
-- |
-- |
What is the 52 Week High and Low of Revelation Biosciences Inc (REVBU)?
The 52-week high and low of Revelation Biosciences Inc (REVBU) are Rs -- and Rs -- as of 05-Sep-2026.
What is the market cap of Revelation Biosciences Inc (REVBU)?
Revelation Biosciences Inc (REVBU) has a market capitalisation of -- as on 20-Jan-2023. As per SEBI classification, it is a company.
Should I invest in Revelation Biosciences Inc (REVBU)?
Before investing in Revelation Biosciences Inc (REVBU), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.